A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Groups,Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of KSB-10301 versus Placebo in Elderly Patients with Sarcopenia
100 Clinical Results associated with KSB TUGEN
0 Patents (Medical) associated with KSB TUGEN
100 Deals associated with KSB TUGEN
100 Translational Medicine associated with KSB TUGEN